Relationship between Serum Bilirubin Levels and Metabolic Syndrome in Patients with Schizophrenia Spectrum Disorders

다국어 초록 (Multilingual Abstract)

Objective: We investigated the relationship between serum bilirubin levels and metabolic syndrome (MetS), and the longitudinal effects of baseline serum bilirubin concentrations on MetS in patients with schizophrenia spectrum disorders undergoing atypical antipsychotics.
Methods: The sample of this study consisted of 131 patients with schizophrenia spectrum disorders. Waist circumference, blood pressure, and levels of triglycerides, high-density lipoprotein cholesterol, fasting glucose, and insulin were evaluated at baseline and at month six. Serum bilirubin levels were measured at baseline. Serum bilirubin levels of the patients with and without MetS criteria were compared. We also compared patients with high and low bilirubin levels (upper and lower 50th percentiles of serum bilirubin levels) in terms of MetS criteria, MetS frequency, and course of MetS.
Results: Serum direct bilirubin levels were more consistently related to MetS and MetS-related variables. The waist circumference and triglyceride criteria for MetS were significantly related to low serum direct bilirubin at baseline; waist circumference and fasting glucose criteria, and insulin resistance were associated with low serum direct bilirubin at follow-up. MetS diagnosis and the presence of the waist circumference criterion were more frequent at the baseline and the follow-up in low bilirubin group.
At the end of the follow-up period, the rate of reverse MetS was significantly higher in the high bilirubin group.
Conclusion: Our results have suggested that serum direct bilirubin levels showed a more reliable and stable relationship with abdominal obesity for MetS components.in patients with schizophrenia spectrum disorders using antipsychotics. Further studies are required.

참고문헌 (Reference)

1 Jo J, "Total, direct, and indirect serum bilirubin concentrations and metabolic syndrome among the Korean population" 39 : 182-189, 2011

2 Vítek L, "The role of bilirubin in diabetes, metabolic syndrome, and cardiovascular diseases" 3 : 55-, 2012

3 Perlstein TS, "Serum total bilirubin level and prevalent lower-extremity peripheral arterial disease : National Health and Nutrition Examination Survey(NHANES)1999 to 2004" 28 : 166-172, 2008

4 Onat A, "Serum bilirubin levels in Turkish adults show inverse relation with insulin resistance and overall obesity, without association with metabolic syndrome" 35 : 28-36, 2007

5 Jenko-Pražnikar Z, "Serum bilirubin levels are lower in overweight asymptomatic middle-aged adults: an early indicator of metabolic syndrome?" 62 : 976-985, 2013

6 Lin LY, "Serum bilirubin is inversely associated with insulin resistance and metabolic syndrome among children and adolescents" 203 : 563-568, 2009

7 Breimer LH, "Serum bilirubin and risk of ischemic heart disease in middle-aged British men" 41 : 1504-1508, 1995

8 Ko GT, "Serum bilirubin and cardiovascular risk factors in a Chinese population" 3 : 459-463, 1996

9 Newcomer JW, "Second-generation(atypical)antipsychotics and metabolic effects : a comprehensive literature review" 19 (19): 1-93, 2005

10 Andreasen NC, "Scale for the assessment of positive symptoms (SAPS)" Department of Psychiatry College of Medicine, The University of Iowa 1984

11 Andreasen NC, "Scale for the assessment of negative symptoms (SANS)" Department of Psychiatry College of Medicine, The University of Iowa 1983

12 Andersson C, "SCOUT Executive Steering Committee; SCOUT investigators. Acute effect of weight loss on levels of total bilirubin in obese, cardiovascular high-risk patients:an analysis from the lead-in period of the Sibutramine Cardiovascular Outcome trial" 58 : 1109-1115, 2009

13 Choi SH, "Relationships between serum total bilirubin levels and metabolic syndrome in Korean adults" 23 : 31-37, 2013

14 Yoshino S, "Relationship between bilirubin concentration, coronary endothelial function, and inflammatory stress in overweight patients" 18 : 403-412, 2011

15 Giral P, "Plasma bilirubin and gamma-glutamyltransferase activity are inversely related in dyslipidemic patients with metabolic syndrome : relevance to oxidative stress" 210 : 607-613, 2010

16 "Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee" 854 : 1-452, 1995

17 Henderson DC, "Pathophysiological mechanisms of increased cardiometabolic risk in people with schizophrenia and other severe mental illnesses" 2 : 452-464, 2015

18 Alberti KG, "Metabolic syndrome--a new world-wide definition. A Consensus Statement from the International Diabetes Federation" 23 : 469-480, 2006

19 Hasnain M, "Metabolic syndrome associated with schizophrenia and atypical antipsychotics" 10 : 209-216, 2010

20 Wu Y, "Low serum total bilirubin concentrations are associated with increased prevalence of metabolic syndrome in Chinese" 3 : 217-224, 2011

21 Erdogan D, "Low serum bilirubin levels are independently and inversely related to impaired flow-mediated vasodilation and increased carotid intima-media thickness in both men and women" 184 : 431-437, 2006

22 Novotný L, "Inverse relationship between serum bilirubin and atherosclerosis in men : a meta-analysis of published studies" 568-571, 2003

23 Hwang HJ, "Inverse relationship between fasting direct bilirubin and metabolic syndrome in Korean adults" 411 : 1496-1501, 2010

24 Kwon KM, "Inverse association between total bilirubin and metabolic syndrome in rural Korean women" 20 : 963-969, 2011

25 Druss BG, "Integrated medical care for patients with serious psychiatric illness : a randomized trial" 58 : 861-868, 2001

26 Vítek L, "Gilbert syndrome and ischemic heart disease : a protective effect of elevated bilirubin levels" 160 : 449-456, 2002

27 Bach DR, "Elevated bilirubin in acute and transient psychotic disorder" 43 : 12-16, 2010

28 Cohn T, "Characterizing coronary heart disease risk in chronic schizophrenia : high prevalence of the metabolic syndrome" 49 : 753-760, 2004

29 Bulmer AC, "Bilirubin and beyond : a review of lipid status in Gilbert's syndrome and its relevance to cardiovascular disease protection" 52 : 193-205, 2013

30 Radhakrishnan R, "Association between unconjugated bilirubin and schizophrenia" 189 : 480-482, 2011

31 McArdle PF, "Association between bilirubin and cardiovascular disease risk factors : using Mendelian randomization to assess causal inference" 12 : 16-, 2012

32 Torgerson JS, "Are elevated aminotransferases and decreased bilirubin additional characteristics of the metabolic syndrome?" 5 : 105-114, 1997

33 Balci Sengul C, "Antipsychotics and metabolic syndrome: a naturalistic six-month follow-up study" 23 (23): S138-, 2013

34 Saha S, "A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time?" 64 : 1123-1131, 2007

35 Atasoy N, "A review of liver function tests during treatment with atypical antipsychotic drugs : a chart review study" 31 : 1255-1260, 2007

36 Chang Y, "A cohort study of serum bilirubin levels and incident non-alcoholic fatty liver disease in middle aged Korean workers" 7 : e37241-, 2012